Nature Biotechnology, Published online: 30 June 2026; doi:10.1038/s41587-026-03201-5
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Liberate Bio is developing a lipid nanoparticle toolbox to deliver genetic medicine to previously inaccessible cells inside the body.